News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Salix Pharmaceuticals, Ltd. (SLXP) Announces Approval of Merger With InKine Pharmaceutical Company, Inc. (INKP)


10/19/2005 5:13:08 PM

RALEIGH, N.C.--(BUSINESS WIRE)--Sept. 30, 2005--Salix Pharmaceuticals, Ltd. (NASDAQ:SLXP) and InKine Pharmaceutical Company, Inc. (NASDAQ:INKP) announced that earlier today the stockholders of both companies approved the merger of the two companies, creating the largest US specialty pharmaceutical company focused exclusively on gastroenterology. Subject to a certificate of merger being filed with the New York Department of State and other standard closing conditions, the merger is expected to be effective later today.

Read at BioSpace.com

Related News

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES